28 results
F-3
BWAY
Brainsway Ltd
17 Sep 21
Shelf registration (foreign)
4:06pm
to conduct additional research into other indications, including addictions such as opioid addiction and/or alcohol addiction, and into neurological
SC TO-I
EX-99
BWAY
Brainsway Ltd
4 May 21
Issuer tender offer statement
9:28am
research into other indications, including addictions such as opioid addiction and/or alcohol addiction, and into neurological conditions including
424B5
h0qfok
24 Feb 21
Prospectus supplement for primary offering
4:31pm
424B5
iriym
22 Feb 21
Prospectus supplement for primary offering
5:08pm
F-3
a90lne7ytrv6k123k7t
4 Sep 20
Shelf registration (foreign)
9:37am
20-F
c5qjqu9s
23 Mar 20
Annual report (foreign)
8:02am
6-K
EX-99.1
khb3dq1sywl gtpjge0e
25 Nov 19
BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights
7:00am
6-K
EX-99.1
i3xyxg2cl0rpyb
14 Nov 19
Current report (foreign)
4:01pm
6-K
EX-99.1
4u4f8t0dzdpnxgil
19 Sep 19
Company Intends to Appoint U.S.-Based CEO
10:10am
6-K
EX-99.1
uf9 w7gmwu7b
26 Aug 19
Brainsway Reports Second Quarter 2019 Financial Results and Operational Highlights
7:00am
6-K
EX-99.1
49aj5fyqlzxb1a
14 Aug 19
Current report (foreign)
12:00am
6-K
EX-99.1
s7a67zhizylh4rntht
18 Jul 19
Current report (foreign)
7:00am
6-K
EX-99.1
spzve59rxqq
17 Jun 19
Brainsway Announces Changes to its Board of Directors
7:00am
6-K
EX-99.1
zqzrrbra59
29 May 19
Brainsway Reports First Quarter 2019 Financial Results and Operational Highlights
7:00am
6-K
EX-99.1
omq6l33vuk3feecdu
23 May 19
Current report (foreign)
7:00am
6-K
EX-99.1
evnoiyk
22 May 19
BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment
7:01am
6-K
EX-99.1
c06x5u6dz1xc4lf2 kd
22 Apr 19
Brainsway Ltd. Announces Closing of Initial Public Offering
4:00pm